Skip to main content
. 2021 Aug 12;14:4459–4468. doi: 10.2147/IJGM.S325907

Table 3.

NRI and IDI Analyses for Risk Reclassification of in Hospital Mortality in Original Cohort and Matched Cohort

Outcome Sensibility (%) Specificity (%) AUC IDI NRIa
Biomaker Biomaker+Clinical Model Clinical Modelb P valuec Value (95% CI) P value Value (95% CI) P value
Original Cohort
 LMR 65.0 67.3 0.706 0.795 0.751 <0.001 0.021(0.003–0.045) 0.020 0.121(0.014–0.214) <0.001
 SOFA 60.8 62.9 0.658 0.793 0.086 −0.002(−0.007–0.005) 0.515 −0.023(−0.124–0.062) 0.614
 LMR+SOFA 60.6 72.0 0.710 0.798 0.001 0.018(0.001–0.045) 0.045 0.110(0.001–0.216) 0.030
Matched 1cohort
 LMR 56.7 75.7 0.707 0.785 0.770 0.017 0.032(0.007–0.058) <0.001 0.124(0.007–0.246) 0.031
 SOFA 60.9 65.5 0.671 0.777 0.054 0.012(−0.002–0.035) 0.109 0.055(−0.060–0.176) 0.259
 LMR+SOFA 63.3 69.4 0.714 0.799 0.013 0.032(0.010–0.057) 0.011 0.104(0.001–0.249) 0.045

Notes: aThe NRI is calculated through two-way category by using the event rate of in hospital mortality, bThe clinical model for predicting in hospital mortality are composed of age, gender, weight, ethnicity, comorbidities, interventions, vital signs and laboratory results, cBiomarker+clinical model versus clinical model. It would be better if significant p values were expressed in bold characters.

Abbreviations: AUC, area under the receiver-operating characteristic curve; IDI, integrated discrimination improvement; NRI, net reclassification index; LMR, lymphocyte-to-monocyte ratio, SOFA, sequential organ failure assessment.